Table Of Contents

1. Introduction 18
1.1. Objectives Of The Study 18
1.2. Market Definition 18
1.3. Overview Of Europe Microfluidics Market 18
1.4. Currency And Pricing 19
1.5. Limitation 19
1.6. Markets Covered 20
2. Market Segmentation 22
2.1. Markets Covered 22
2.2. Geographic Scope 23
2.3. Years Considered For The Study 24
2.4. Currency And Pricing 24
2.5. Research Methodology 25
2.6. Primary Interviews With Key Opinion Leaders 28
2.7. Secondary Sources 29
2.8. Assumptions 29
3. Market Overview 30
3.1. Drivers 32
3.1.1. Increased Demand Of Poc Testing 32
3.1.2. Wide Range Of Applications In Different Sectors 33
3.1.3. Benefits Associated With Incorporation Of Microfluidics 34
3.1.4. High Return On Investments 35
3.2. Restraints 37
3.2.1. Complexity In Incorporating Microfluidics Technology In The Existing Procedures 37
3.3. Opportunities 38
3.3.1. Lucrative Opportunities In Emerging Region 38
3.3.2. Rise In The Drug Discovery Research 40
3.4. Challenges 40
3.4.1. Lack Of Visibility In The Market 40
4. Executive Summary 41
5. Premium Insights 43
6. Europe Microfluidics Market, By Component 46
6.1. Overview 47
6.2. Microfluidics Chips 48
6.3. Micropumps 50
6.4. Microneedles 52
6.5. Others 54
7. Europe Microfluidics Market, By Material 56
7.1. Overview 57
7.2. Polymer 58
7.3. Glass 60
7.4. Silicon 61
7.5. Others 62
8. Europe Microfluidics Market, By Sector 63
8.1. Overview 64
8.2. Healthcare 66
8.2.1. Poc Diagnostics 68
8.2.2. Cell Analysis 68
8.2.3. Drug Discovery 68
8.2.4. Immunoassays 69
8.2.5. Genotyping & Sequencing 69
8.2.6. Microarray Analysis 69
8.2.7. In-Vitro Diagnostics 70
8.2.8. Biomarker Analysis 70
8.2.9. Others 70
8.3. Industrial 71
8.3.1. Biotechnology 72
8.3.2. Energy 73
8.3.3. Nutraceuticals & Food 73
8.3.4. Cosmetics 73
8.3.5. Chemical 74
9. Europe Microfluidics Market, By End User 75
9.1. Overview 76
9.2. Hospitals 78
9.3. Research Laboratories & Academia 79
9.4. Industrial R&D 80
10. Europe Microfluidics Market, By Geography 81
10.1. Europe 81
10.1.1. Germany 92
10.1.2. France 97
10.1.3. U.K. 101
10.1.4. Italy 105
10.1.5. Spain 109
10.1.6. Netherlands 113
10.1.7. Switzerland 118
10.1.8. Belgium 122
10.1.9. Russia 126
10.1.10. Turkey 130
10.1.11. Rest Of Europe 134
11. Europe Microfluidics Market, Company Landscape 135
11.1. Company Share Analysis; Europe 135
12. Company Profiles 136
12.1. Perkinelmer Inc. 136
12.1.1. Company Overview 136
12.1.2. Perkinelmer Inc.; Revenue Analysis 137
12.1.3. Product Portfolio 138
12.1.4. Recent Developments 140
12.2. Dolomite Microfluidics 141
12.2.1. Company Overview 141
12.2.2. Dolomite Microfluidics; Company Snapshot 141
12.2.3. Product Portfolio 142
12.2.4. Recent Developments 144
12.3. Microfluidics 146
12.3.1. Company Overview 146
12.3.2. Microfluidics; Company Snapshot 146
12.3.3. Product Portfolio 147
12.3.4. Recent Developments 148
12.4. Abaxis 149
12.4.1. Company Overview 149
12.4.2. Abaxis; Revenue Analysis 149
12.4.3. Product Portfolio 150
12.4.4. Recent Developments 150
12.5. Abbott 151
12.5.1. Company Overview 151
12.5.2. Abbott; Revenue Analysis 151
12.5.3. Product Portfolio 152
12.5.4. Recent Developments 152
12.6. Agilent Technologies 153
12.6.1. Company Overview 153
12.6.2. Agilent Technologies;Revenue Analysis 153
12.6.3. Product Portfolio 154
12.6.4. Recent Developments 154
12.7. Akonni Biosystems Inc. 155
12.7.1. Company Overview 155
12.7.2. Akonni Biosystems, Inc.; Company Snapshot 155
12.7.3. Product Portfolio 156
12.7.4. Recent Developments 156
12.8. Aviva Biosciences 157
12.8.1. Company Overview 157
12.8.2. Aviva Biosciences; Company Snapshot 157
12.8.3. Product Portfolio 157
12.8.4. Recent Developments 157
12.9. Bio-Rad Laboratories Inc. 158
12.9.1. Company Overview 158
12.9.2. Bio-Rad Laboratories, Inc.; Revenue Analysis 158
12.9.3. Product Portfolio 159
12.9.4. Recent Developments 159
12.10. Cepheid 160
12.10.1. Company Overview 160
12.10.2. Cepheid; Company Snapshot 160
12.10.3. Product Portfolio 160
12.10.4. Recent Developments 160
12.11. Fluxion Bioscience 161
12.11.1. Company Overview 161
12.11.2. Fluxion Bioscience; Company Snapshot 161
12.11.3. Product Portfolio 162
12.11.4. Recent Developments 162
12.12. Hewlett-Packard 163
12.12.1. Company Overview 163
12.12.2. Hp Inc.; Revenue Analysis 163
12.12.3. Product Portfolio 164
12.12.4. Recent Developments 164
12.13. Illumina Inc. 165
12.13.1. Company Overview 165
12.13.2. Illumina, Inc.;Revenue Analysis 165
12.13.3. Product Portfolio 166
12.13.4. Recent Developments 166
12.14. Raindance Technologies Inc. 167
12.14.1. Company Overview 167
12.14.2. Raindance Technologies, Inc.; Company Snapshot 167
12.14.3. Product Portfolio 168
12.14.4. Recent Developments 168
12.15. Thermo Fisher Scientific Inc. 169
12.15.1. Company Overview 169
12.15.2. Thermo Fisher Scientific Inc. ;Revenue Analysis 169
12.15.3. Product Portfolio 170
12.15.4. Recent Developments 170
13. Related Reports 171

?